MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.

Aviron Ltd engages in the research and development of specific antiviral agents against chronic Hepatitis C Virus (HCV) infection. The company has strategic alliances with CHEMRAR Hi-Tech Center, Chemical Diversity Research Institute, and DRUGS TECHNOLOGY, Ltd. Aviron Ltd was founded in 2010 and is based in Moscow, Russian Federation.

Kyoritsu Seiyaku Corp. engages in the research, development, and production of vaccines and drugs for pets, livestock, and marine animals. It also deals with the manufacture of industrial and general deodorizers. The company was founded on May 19, 1955 and is headquartered in Tokyo, Japan.

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.

Zhaoqing Dahuanong Biopharmaceutical Co., Ltd., established on 2002-07-22, The business scope includes the production of veterinary vaccines;sales of veterinary drugs;Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).The branch produces inactivated embryotoxin vaccines;Sales of veterinary biological products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Weilide Biopharmaceutical Co., Ltd., established on 2012-12-24, The scope of business includes research and development of biomedical products and related technical services.(In the scope of the above, the state-owned special regulations need to be examined and approved. The project can only be operated after approval or with a valid license.)

Jilin Guanjie Biotechnology Co., Ltd., established on 2009-04-15, The business scope includes the production of veterinary drugs;For the production and sales of veterinary biological products,research and development,consult,;Production and sales of veterinary equipment;Processing and sales of raw materials for veterinary biological products;technology transfer;Acting import and export business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Seqirus has manufacturing facilities on three continents and a globally integrated supply chain to ensure that the influenza vaccine is delivered on time to customers. They have one of the industry's most extensive influenza vaccination portfolios, customized to the needs of health care providers and their patients.

Wuhan Institute of Biological Products Co., Ltd. is a Chinese company located in Wuhan and ultimately controlled by the Government of China that develops vaccines and immunization products.

Since the establishment of Sunkyung Textiles in 1969, SK Chemicals has grown through continuous change and innovation into a chemical and life sciences enterprise representing South Korea. SK Chemicals’ new mission statement says, "They enhance human health and protect the Earth’s environment" and they have reorganized their business structure to focus on the two large sectors of green chemicals and life sciences. Providing distinguished chemical and life sciences products and solutions based on the world's highest technology standards, SK Chemicals is recognized as a leading global company of environmentally-friendly materials and total healthcare solutions. Their green chemical business is steadily progressing as a leading global company in the environmentally-friendly materials business by using the world’s best technology, knowledge, and production facilities. To achieve this goal, SK Chemicals has selected four new core areas of business: bio-materials, composites, high-performance materials, and energy saving materials while continuing a commitment to R&D activities.

The Chemo-Sero Therapeutic Research Institute operates as a pharmaceutical company specializing in the field of biotechnology, immunology, hematology, and microbiology. It develops and manufactures vaccines and blood plasma products. The firm's products include human and veterinary vaccines, diagnostic antigens, and treatments for congenital disorders. They also provides newborn screening tests and quality assurance systems solutions. The company was founded on December 26, 1945 and is headquartered in Kumamoto, Japan.

Guangdong Wen's Dahuanong Biotechnology Co., Ltd., established on 2015-08-04, Business scope includes licensed projects:Veterinary drug production;Veterinary drug business;Experimental animal management;Experimental animal production;feed production;Feed additive production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Feed Raw Material Sales;Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;Purchase of primary agricultural products;Agricultural Science Research and Experimental Development;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.

Wuhan Shengda Kang Biotechnology Co., Ltd., established on 2010-10-19, The scope of business includes the development of biotechnology product technology,technical consulting,technology transfer,Technical Services;electrical equipment,Office Supplies,building materials,electronic product,Chemical Products,Scientific reagents,chemical reagent,disinfectant(None of the above contain hazardous chemicals),Instrumentation,Experimental equipment and consumables,handcrafted gift,Daily necessities,Cosmetic sales.(In the above business scope, the projects with special regulations stipulated by the state can only be operated after approval or with a valid license);medical instrumentsII,IIIclass business.(Operate within the approved scope and time limit with the license)(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Chengdu Shiji Bio-Pharmaceutical Co., Ltd., established on 2003-04-15, Business scope includes licensed projects:Veterinary drug production;Veterinary drug business;Breeding livestock and poultry management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Agricultural Science Research and Experimental Development;Bio-feed R&D;Pet Food and Supplies Wholesale;Pet food and supplies retail;Experimental analysis instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;internet sales(Except for products that require a license for sale);Import and export;Technology Import and Export;Import and export agency;farming,Forest,animal husbandry,vice,Sales of fishery specialized machinery(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Huanong (Zhaoqing) Bio-Industry Technology Research Institute Co., Ltd., established on 2017-01-26, The scope of business includes the provision of biotechnology,Marine fish farming,Project R&D services in food safety and other related technical fields,Transformation of scientific and technological achievements,Project development and introduction,Provide technical and consulting services for related projects and industries;Veterinary Services;Agricultural Services;design,processing(pilot test),Sales:Biotechnology Related Products,and provide related services;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chiron Behring & Co., a subsidiary of Novartis AG, is a German company located in Marburg that supplies and developes new vaccine products for adults and children. The firm was acquired by Chiron Corp. from Hoechst AG on April 01, 1998 for $111.90 million.